| Glaxosmithkline Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500660 |
NSE Symbol : GLAXO |
P/E(TTM) : 45.52 |
|
ISIN Demat : INE159A01016 |
Div & Yield% : 2.12 |
EPS(TTM) : 55.87 |
|
Book Value(₹) : 100.52 |
Market Cap(₹Cr) : 43,081.65 |
Face Value(₹) : 10.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3,723.49 | 3,407.25 | 3,216.34 | 3,217.51 | 2,920.48 |
| Other Income | 147.26 | 143.17 | 114.96 | 1,423.27 | 217.71 |
| Stock Adjustments | -51.23 | 69.64 | -67.25 | -13.83 | 26.12 |
| Total Income | 3,819.52 | 3,620.06 | 3,264.05 | 4,626.95 | 3,164.31 |
| EXPENDITURE : | |||||
| Raw Materials | 1,315.97 | 1,358.07 | 1,182.78 | 1,281.91 | 1,275.49 |
| Power and Fuel Cost | 30.18 | 29.64 | 29.60 | 27.83 | 26.08 |
| Other Manufacturing Expenses | 114.26 | 113.61 | 99.05 | 120.14 | 110.59 |
| Selling and Administration Expenses | 383.95 | 374.71 | 370.30 | 343.57 | 242.00 |
| Miscellaneous Expenses | 78.91 | 239.12 | 84.32 | 85.69 | 287.75 |
| Employee Benefit Expenses | 579.70 | 624.39 | 594.99 | 610.23 | 616.16 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,316.54 | 880.52 | 903.01 | 2,157.57 | 606.24 |
| Interest | 1.31 | 1.80 | 1.81 | 1.99 | 3.53 |
| Gross Profit | 1,315.23 | 878.72 | 901.20 | 2,155.58 | 602.71 |
| Depreciation | 66.79 | 69.68 | 65.77 | 68.19 | 78.60 |
| Profit Before Tax | 1,248.44 | 809.04 | 835.43 | 2,087.39 | 524.11 |
| Current Tax | 323.18 | 235.71 | 246.05 | 407.36 | 158.67 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 6.20 | -11.36 | -18.37 | -10.49 | 7.87 |
| Reported Net Profit | 919.05 | 584.69 | 607.75 | 1,690.53 | 357.57 |
| Extraordinary Items | 53.61 | -66.58 | 21.05 | 11.18 | -117.79 |
| Adjusted Net Profit | 865.44 | 651.27 | 586.70 | 1,679.35 | 475.36 |
| Adjustment below Net Profit | 0.00 | 0.00 | -17.08 | -11.05 | 0.00 |
| Profit/Loss Balance carried down | 870.71 | 828.12 | 1,745.02 | 562.71 | 882.77 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 745.39 | 542.10 | 1,524.66 | 508.22 | 677.62 |
| P & L Balance carried down | 1,044.37 | 870.71 | 811.03 | 1,733.98 | 562.71 |
| Dividend | 203.29 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 540.00 | 320.00 | 320.00 | 900.00 | 300.00 |
| Dividend Per Share(Rs) | 54.00 | 32.00 | 32.00 | 90.00 | 30.00 |
| Earnings Per Share-Unit Curr | 54.25 | 34.51 | 35.88 | 99.79 | 21.11 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 115.06 | 105.31 | 103.48 | 158.06 | 88.37 |
| Book Value(Adj)-Unit Curr | 115.06 | 105.31 | 103.48 | 158.06 | 88.37 |